| dc.contributor.author | Mettananda, C, | |
| dc.contributor.author | Peiris, C. | |
| dc.contributor.author | Abeyrathna, D. | |
| dc.contributor.author | Gunasekera, A. | |
| dc.contributor.author | Egodage, T. | |
| dc.contributor.author | Danthanarayana, C. | |
| dc.contributor.author | Pathmeswaran, A. | |
| dc.contributor.author | Ranasinha, C. | |
| dc.date.accessioned | 2024-01-09T09:23:15Z | |
| dc.date.available | 2024-01-09T09:23:15Z | |
| dc.date.issued | 2023 | |
| dc.identifier.citation | Clinical Medicine.2023;23(Suppl 6):66-68 | en_US |
| dc.identifier.issn | 1470-2118 (Print) | |
| dc.identifier.issn | 1473-4893 (Electronic) | |
| dc.identifier.uri | http://repository.kln.ac.lk/handle/123456789/27178 | |
| dc.description | Indexed in MEDLINE | en_US |
| dc.description.abstract | No abstract available | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | The College | en_US |
| dc.subject | COVID-19 | en_US |
| dc.title | Inhaled beclomethasone in the treatment of early COVID-19: a phase 2, double-blind, placebo-controlled, randomised trial | en_US |
| dc.type | Article | en_US |
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||